|
|
![]() |
Healthcare-associated infection — hospital-acquired infection |
By Conor Jamieson, PhD, MRPharmS |
Healthcare-associated infections represent a massive challenge currently facing the NHS. Pharmacists must play their part in the management of infected patients and be aware of strategies that prevent one infection becoming an outbreak |
This article as a PDF (60K) |
SUMMARY Recent outbreaks of uncontrolled healthcare-associated infection (HCAI)
have demonstrated the devastating impact that such infections can have
on the health services operationally, politically and in terms of patient
morbidity and mortality. However, if the infecting organism is introduced to the body
by an invasive healthcare intervention, it is considered an intervention-related
infection. This is discussed separately (p13). Political drive Controlling HCAIs is a key focus for the Department of Health, which in 2004, announced a target to halve the national incidence of MRSA (meticillin-resistant Staphylococcus aureus) infections by 2008 (based on figures for 2003). Guidance on reducing HCAIs has been
published
by the DoH and trusts are now required to produce frequent reports on
HCAI incidence rates. Another HCAI that will be included in these reports
is Clostridium difficile-associated diarrhoea, for which the national
incidence is continuing to increase. However, working to prevent and control HCAIs is the responsibility of all members of the healthcare team. |